MARKER THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-27.3M | $-27.3M | — | $6.0M |
| FY2022 | $-27.0M | $-27.0M | — | $3.3M |
| FY2023 | $-16.4M | $-16.4M | — | $858.3K |
| FY2024 | $-10.9M | $-10.9M | — | $245.9K |
| FY2025 | $-12.0M | $-12.0M | — | $537.5K |